Calcium channel-blocking drugs: a novel intervention for the treatment of cardiac disease. Introduction
Schwartz, A.; Taira, N.
Circulation Research 52(2 Pt 2): I1-I2
1983
ISSN/ISBN: 0009-7330 PMID: 6831644 Document Number: 198506
Document emailed within 1 workday
Related Documents
Brill, D.M.; Fozzard, H.A. 1985: Calcium channel blocking drugs. Part II: Clinical applications Comprehensive Therapy 11(10): 67-71Moss, A.J. 1986: Current status of calcium channel blocking drugs after myocardial infarction European Heart Journal 7 Suppl A: 31-34
Pentel, P.R.; Salerno, D.M. 1990: Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents Medical Journal of Australia 152(2): 88-94
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Cascone, A.; Ferrari, F.; Alaimo, A.; Daprati, A.; Cascone, G. 1985: Treatment of arterial hypertension with a calcium-channel blocking agent, nicardipine hydrochloride Bollettino Chimico Farmaceutico 124(5): 37S-42S
Lopes, H.F.; Silva, H.B.; Bellotti, G.; Pillegi, F. 1990: Efficacy and tolerance of a new calcium-channel blocking agent (nitrendipine) in the treatment of arterial hypertension Arquivos Brasileiros de Cardiologia 54(3): 227-229
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Birx, D.L.; Berger, M.; Fleisher, T.A. 1984: The interference of T cell activation by calcium channel blocking agents Journal of Immunology 133(6): 2904-2909
Barbato, F.; Grumetto, L.; Morrica, P. 1994: Analysis of calcium channel blocking dihydropyridines and their degradation products by gas chromatography Farmaco 49(7-8): 461-466
Glossmann, H.; Ferry, D.R.; Goll, A.; Striessnig, J.; Zernig, G. 1985: Calcium channels and calcium channel drugs: recent biochemical and biophysical findings Arzneimittel-Forschung 35(12a): 1917-1935
Schneider, W.; Kaltenback, M. 1988: The use of beta-blockers in unstable angina: comparison with calcium channel blocking agents Journal of Cardiovascular Pharmacology 12(Suppl 1): S78-S82
Horiuchi, H.; Yano, S.; Watanabe, K.; Yamanaka, E.; Aimi, N.; Sakai, S. 1988: Structure specificities of yohimbine and indoloquinolizidine derivatives in blocking alpha-adrenoceptor and calcium channel Research Communications in Chemical Pathology and Pharmacology 59(3): 407-410
Nakaya, H.; Kanno, M.; Kanda, K.; Oyama, Y. 1980: Electrophysiologic effects of calcium channel blocking agents on the sinus node function in anesthetized dogs Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(8): 697-707
Bultas, J. 1995: Calcium channel blockers in the treatment of ischemic heart disease Vnitrni Lekarstvi 41(3): 167-168
Resnekov, L. 1982: Calcium ion blocking drugs Comprehensive Therapy 8(7): 10-15
Chah, Q.T.; Bertrix, L.; Bouzouita, K.; Lang, J.; Faucon, G. 1983: Study of the ventricular antifibrillatory effects of calcium channel blocking agents in comparison with lidocaine on canine normal heart in situ Archives Internationales de Pharmacodynamie et de Therapie 261(2): 238-248
Triggle, D.J. 1991: Calcium-channel drugs: structure-function relationships and selectivity of action Journal of Cardiovascular Pharmacology 18(Suppl 10): S1-S6
Shaw, K.P.; Aracava, Y.; Akaike, A.; Daly, J.W.; Rickett, D.L.; Albuquerque, E.X. 1985: The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex Molecular Pharmacology 28(6): 527-538
Gout, B.; Jean, J.; Bril, A. 1992: Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function Journal of Pharmacology and Experimental Therapeutics 262(3): 987-994